 Home > Biochemistry News > Biotechnology News > EU approves Merck's Keytruda combined with chemotherapy for triple-negative breast cancer

EU approves Merck's Keytruda combined with chemotherapy for triple-negative breast cancer

 Last Update: 2021-11-01
 Source: Internet
 Author: User

Tags

cocamidopropyl betaine cancer

cbd breast milk

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

CompilationFan Dongdong

A few days ago, the European Commission announced the approval of Merck’s anti-PD-1 therapy Keytruda combined with chemotherapy for the first-line treatment of locally recurrent unresectable or metastatic triple-negative breast cancer in adults with tumors

Just a month ago, the combination of Keytruda and chemotherapy for triple-negative breast cancer has just received a positive recommendation from the European Medicines Agency (EMA) Committee on Medicines for Human Use (CHMP)

Triple-negative breast cancer is an aggressive breast cancer.

The approval is based on the positive results of the pivotal Phase 3 KEYNOTE-355 trial (NCT02819518)

The results of the KEYNOTE-355 trial showed that compared with patients who received chemotherapy alone, PFS and OS were significantly improved in patients who received Keytruda combined with chemotherapy

The Keytruda combination chemotherapy has been approved for the treatment of breast cancer and will allow Keytruda to be marketed and marketed in all 27 EU member states as well as Iceland, Liechtenstein, Norway and Northern Ireland

Reference source: EU Approves Merck's Keytruda Plus Chemotherapy To Treat Triple-Negative Breast Cancer

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.